The Export-Import Bank of Korea (Eximbank) issued "kangaroo bonds" worth 700 million Australian dollars to expand its foothold overseas.
The lender decided recently to issue the bonds after observing rising investor confidence in Australia.
The dual-tranche bonds consisted of 200 million Australian dollars issued with a fixed rate of 1.311 percent, with the rest having an interest rate of 1.07 percent, plus the bank bill swap rate.
The maturity of the bond is three years.
Fifty-seven investors placed orders worth 1.7 billion Australian dollars for the bonds.
With the move, Eximbank became the first Asian financial organization to issue the bonds since the coronavirus pandemic hit the global economy.
Eximbank has also issued the largest amount of Kangaroo bonds among Asian organizations, reaching 4.8 billion Australian dollars worth since 2012.
According to an Eximbank representative, they were doing their utmost to expand their financing channels and reaffirmed that its Kangaroo bonds were trustworthy enough for overseas investors.
It's the first time that a Korean organization issued kangaroo bonds since October 2019 when Korea Southern Power Co. issued 300 million Australian dollars worth.


CK Hutchison Seeks $1.5 Billion From Panama Over Canal Ports
Coty Revenue Beats Estimates as Beauty Demand Holds Firm
Nordson Stock Rises as Q3 Earnings Beat Estimates, Outlook Raised
Moody’s Upgrades Vodafone Hybrid Debt Ratings to Baa3
Alphabet Eyes First Australian Dollar Bond as AI Spending Drives Funding Push
Moody’s Affirms NVIDIA Aa1 Rating as AI Data Center Guarantees Reach $105 Billion
Alibaba Sells Lingxi Games for Over $1.5 Billion Amid AI Push
Baidu Shares Sink to One-Year Low as Ad Weakness Overshadows AI Growth
Hermès Stock Downgraded by RBC as Luxury Growth Premium Narrows
Anthropic Eyes $10B-Plus Credit Line Ahead of Potential IPO
REPAY Stock Rises After Visa Platform Connect Collaboration
Standard Chartered Expands Hedge Fund Access for Wealth Clients
Samsung Eyes $72 Billion Shareholder Return Plan as AI Chip Boom Fuels Profits
Moderna Short Sellers Hit With $4.8 Billion Loss as Stock Soars
AstraZeneca Halts Phase III Volrustomig Lung Cancer Trial After Efficacy Setback
Lockheed Martin Secures $153.5 Million in U.S. Defense Contracts 



